CSI Market
Sign In | Register

Novo Nordisk A (NVO) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access NVO quarterly Cash Flow →
The cash flow figures below highlight longer-term patterns in how Novo Nordisk A manages cash inflows and outflows over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
12 Months 		(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Operating Activities
Income19,775.60
Depreciation & amortization3,330.07
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Purchase Of Availableforsale Financial Assets0.00
Share-based Compensation0.00
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction-699.13
Other Adjustments For Noncash Items-3,122.00
Increase Decrease In Working Capital3,737.00
Income Taxes Paid Refund Classified As Operating Activities28,106.00
Income taxes0.00
Purchase Of Intangible Assets Classified As Investing Activities4,540.63
Accounts Receivable0.00
Accounts Payable165.58
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Prepaid Expense and Other Assets-267.99
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-8,801.91
Discontinued operations0.00
Net Cash flow from Operating Activities18,042.84
Investing Activities
Capital Expenditures9,110.65
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Cash Flows From Losing Control Of Subsidiaries Or Other Businesses Classified As Investing Activities-
Dividends Received From Associates Classified As Investing Activities-
Settlement For Prior Years Acquisition Of Business1,004.00
Proceeds From Sale Of Other Financial Assets Classified As Investing Activities30.00
Purchase Of Other Financial Assets Classified As Investing Activities-225.00
Purchase Of Financial Assets Measured At Fair Value Through Profit Or Loss Classified As Investing Activities-498.00
Proceeds From Disposal Of Marketable Securities Classified As Investing Activities10,644.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans370.70
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Purchase Of InterestsIn Associates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net-21,473.05
Discontinued operations0.00
Net Cash Flow from Investing Activities-11,991.70
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net3,538.07
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid-7,841.61
Net Cash Flow from Financing Activities-4,303.55
Effect of exchange rate on cash flow-110.13
Discontinued operations0.00
Free Cash Flow27,153.50
Total Cash Flow2,371.59
4 historic quarters locked

Sign in to unlock the full Novo Nordisk A cash flow history.

Sign In Create Free Account

About Novo Nordisk A S Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 20-F filings and normalized by CSIMarket.

Source & verification

  • Form: 20-F (Period: 20251231)
  • Filed with the SEC: February 4, 2026
  • Source: nvo-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0000353278-26-000012

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License